A new pharmaceutical compliance report shows that less than two-thirds of pharma companies have dedicated compliance departments. "There is no doubt in my mind that companies with dedicated compliance departments are better prepared to handle and adapt to these changes," said lead author David Richardson, senior analyst for Cutting Edge Information. Release